Cryterion Medical

Cryterion Medical is the American company which is engaged in development of the platform of an ablation for treatment of fibrillation of auricles. The producer calls the system the first which is capable to carry out as krio-, and a radio-frequency ablation. The headquarters of Cryterion is in Carlsbad, the State of California (USA). Also there are offices Montreal (Canada) and Wexford (Ireland).

History

2018: Boston Scientific purchased Cryterion Medical

In July, 2018 Boston Scientific announced producer of the medical equipment acquisition of the remained share in Cryterion Medical company. About $202 million Boston Scientific are about purchase of 65% of stocks for the amount sees the big importance in this transaction, considering importance of the technologies developed by Cryterion Medical.

To the patients with fibrillation of auricles extended by violation of a warm rhythm appoint antiarrhytmic medicines or carry out an ablation – impact on a myocardium by a radio-frequency impulse or extremely low temperatures for isolation of the pulmonary veins breaking carrying out normal electroimpulses on auricles. The Cryterion Medical platform uses an advanced balloon catheter with a special covering; a system is intended for process optimization, increase in maneuverability of a catheter and simplification of its positioning at the atypical anatomic building.

Boston Scientific purchased the developer of systems for treatment of violations of a rhythm of heart

The system of an ablation Cryterion Medical undergoes clinical trials in Europe and presumably will go on sale in 2019. By estimates of specialists, quickly growing world market of electrophysiological devices will reach $5 billion by the end of 2018, and instruments of ablatsionny therapy are considered as its most fast-growing segment.

Boston Scientific offers the innovative portfolio of electrophysiological products and services for diagnostics and treatment of violations of a warm rhythm and continues to expand a range of offers by means of internal investments and acquisitions, such as Cryterion Medical.^[1]

Notes